Selective outcome reporting is present in randomized controlled trials in lung cancer immunotherapies

J Clin Epidemiol. 2019 Feb:106:145-146. doi: 10.1016/j.jclinepi.2018.10.010. Epub 2018 Oct 19.

Authors

Reenika Aggarwal¹, Mark Oremus²

Affiliations

¹ School of Public Health and Health Systems, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.
² School of Public Health and Health Systems, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada. Electronic address: moremus@uwaterloo.ca.

PMID: 30342968
DOI: 10.1016/j.jclinepi.2018.10.010

No abstract available

Publication types

Letter

MeSH terms

Humans
Immunotherapy / methods
Lung Neoplasms / immunology*
Lung Neoplasms / therapy*
Publication Bias*
Randomized Controlled Trials as Topic / methods
Randomized Controlled Trials as Topic / standards*
Randomized Controlled Trials as Topic / statistics & numerical data